Development of therapy of acute myeloid leukemia at the first Internal Medicine Clinic in Plzen
Koza, V.; Svojgrová, M.; Slechtová, J.; Pittrová, H.
Vnitrni Lekarstvi 37(2): 160-165
1991
ISSN/ISBN: 0042-773X PMID: 2021076 Document Number: 381742
The authors summarize the development of diagnosis and treatment of acute myeloid leukaemias (AML) at the First Medical Clinic in Plzen in a (group) of 102 patients treated during 1966-1990. On their own results they demonstrate the importance of intensive post-remission treatment with large doses of cytosine arabinoside (ara-c) which makes possible long survival or complete recovery of some patients, and at the same time the necessity and pretentious character of comprehensive supportive treatment is emphasized.
Document emailed within 1 workday
Related Documents
Dasović-Knezević, M.; Knezević, A.; Dujella, J.; Penzar, M. 1984: Development of mucormycosis infection during therapy of chronic myeloid leukemia in the acute stage Medicinski Pregled 37(11-12): 529-531Biukhner, T.; Khiddeman, V.; Mashmeĭer, G.; Liudvig, V.; Lëffler, K.; Novrusian, M.; Aul, S.; Kheĭneke, A. 1991: How to improve results of chemotherapy of acute myeloid leukemia in adults: research of the cooperative group for studying acute myeloid leukemia in West Germany Gematologiia i Transfuziologiia 36(9): 38-40
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Schneck, P. 1993: From clinicum medicum universitatis to Clinic of Internal Medicine of the Berlin Charité--stages in its development Zeitschrift für Arztliche Fortbildung 87(2): 177-182
Zielinski, W.; Goldstein, M.; König, U. 2001: Evidence-based medicine in internal guideline development in a general hospital--the Park-Clinic EbM-Project Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 95(6): 413-417
Kuse, R. 2000: The therapy of acute myeloid leukemia in patients of advanced age Deutsche Medizinische Wochenschrift 125(9): 272
Nawata, R.; Shinohara, K.; Yamada, T.; Takahashi, T.; Katsuki, K.; Takeda, K.; Kameda, N.; Ariyoshi, K.; Ota, I.; Muraki, K. 2000: Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses International Journal of Hematology 71(4): 353-358
Ishikawa, M.; Nakayama, K.; Rahman, M.T.; Rahman, M.; Katagiri, H.; Katagiri, A.; Ishibashi, T.; Iida, K.; Nakayama, N.; Miyazaki, K. 2014: Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report European Journal of Gynaecological Oncology 35(4): 443-448
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Mihailov, G.; Ganeva, P.; Vassileva, N.; Guenova, M.; Balacenko, G.; Toshkov, S.; Hodjadjik, D. 2007: Secondary acute myeloid leukemia early after therapy for Hodgkin's disease--a case report Journal of BUON: Official Journal of the Balkan Union of Oncology 12(3): 403-406
Zingg, K.; von Rohr, A.; Fey, M.F.; Tobler, A. 1994: Prognostic value of bone marrow examinations on day 8 and day 17 of the first induction therapy cycle in acute myeloid leukemia Schweizerische Medizinische Wochenschrift 124(1-2): 51-55
Castagnola, C.; Nozza, A.; Corso, A.; Bernasconi, C. 1997: The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement Haematologica 82(5): 577-580
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086
Morikawa, J.; Li, H.; Kim, S.; Nishi, K.; Ueno, S.; Suh, E.; Dougherty, E.; Shmulevich, I.; Shiku, H.; Zhang, W.; Kobayashi, T. 2003: Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha) International Journal of Oncology 23(3): 617-625
Bakhudze, E.V.; Evstigneeva, L.A.; Leenman, E.E.; Klimashevskiĭ, V.F.; Morozova, E.V.; Shashkova, N.G. 2006: Myeloid sarcoma of the uterine cervix as presentation of acute myeloid leukemia Voprosy Onkologii 52(1): 102-104
Sutoh, H.; Yamauchi, T.; Gotoh, N.; Sugiyama, M.; Ueda, T. 2003: Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia Anticancer Research 23(6d): 5037-5042
Promsuwicha, O.; Auewarakul, C.U. 2009: Positive and negative predictive values of HLA-DR and CD34 in the diagnosis of acute promyelocytic leukemia and other types of acute myeloid leukemia with recurrent chromosomal translocations Asian Pacific Journal of Allergy and Immunology 27(4): 209-216
Horejsí, J.; Hynek 1987: The First Internal Medicine Clinic at the Medical School of Charles University in Prague between two wars. II. What it was like at Hynek's clinic Casopis Lekaru Ceskych 126(28): 887-890
Ludescher, C.; Eisterer, W.; Hilbe, W.; Gotwald, M.; Hofmann, J.; Zabernigg, A.; Cianfriglia, M.; Thaler, J. 1995: Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia Leukemia 9(2): 350-356